Clinical trials
Tetanus clinical trials
Below are recruiting tetanus clinical trials, each written for real people, not researchers. We’re tracking 25 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06344065RecruitingPhase 3
New whooping cough combo vaccine for 3-month-old infants
This trial tests a new combination vaccine that protects infants against diphtheria, tetanus, and whooping cough. It is for healthy 3-month-old babies whose parents have not yet given them a similar shot.
Nanning, GuangxiAges 3 months–3 months - NCT07512167Recruiting
Predicting tetanus survival outcomes using severity scores
This study helps doctors better predict which tetanus patients are at highest risk of dying in the hospital. Researchers will use special scoring systems to identify the most severe cases early so treatment can be adjusted.
CairoAges 18 years+ - NCT07149454Enrolling by invitationPhase 1
Testing a new antibody to prevent tetanus
This trial tests a new medicine made from antibodies that target tetanus toxin. It may help protect people from tetanus without needing a vaccine.
Lanzhou, GansuAges 18–60 - NCT07203755RecruitingPhase 1
Combination vaccine for whooping cough, Hib, and meningitis
This trial tests a new combination vaccine that protects against whooping cough, Haemophilus influenzae type b (a cause of meningitis and pneumonia), and several types of meningococcal disease (a cause of meningitis and bloodstream infections). It may help reduce the number of shots needed for children.
Shangqiu, HenanAges 2 months–6 years - NCT07112144RecruitingPhase 3
DTaP vaccine trial for healthy infants aged 2 months
This trial tests a new vaccine that protects against diphtheria, tetanus, and pertussis (whooping cough). It is for healthy infants who are about 2 months old and live permanently in the area. The goal is to see if the vaccine is safe and works well.
Wenshan Zhuang and Miao Autonomous Prefecture, YunnanAges 2 months–3 months - NCT07621653Recruiting
Safety check-in after meningococcal vaccine in Korea
This study watches for any side effects or health changes after you receive the MenQuadfi vaccine, which protects against four types of meningococcal bacteria. Your doctor will follow up with you to make sure the vaccine is safe and working well.
BusanAges 1 month–55 years - NCT07596199RecruitingPhase 3
Vaccine safety and immune response study in pregnant women
This study tests a vaccine that protects against three diseases—diphtheria, tetanus, and whooping cough—given during pregnancy. Researchers want to see if the vaccine is safe for pregnant women and their babies, and whether it helps protect newborns.
ChibaAges 18–45 - NCT07347938Recruiting
Tetanus prevention after injury: study of siltartoxatug
This study compares a new tetanus shot (siltartoxatug) with standard tetanus treatments to see if it works as well. It is for people aged 18 and older who need tetanus protection after an injury.
Hangzhou, ZhejiangAges 18 years+ - NCT06184542RecruitingPhase 1
New DTaP vaccine safety trial for children
This trial tests a new combined vaccine for diphtheria, tetanus, and whooping cough (pertussis) in children of different ages. It aims to see if the vaccine is safe and how well it works, helping to protect against these serious diseases.
Dazhou, SichuanAges 2 months–6 years - NCT06947499RecruitingPhase 2/Phase 3
Testing a 6-in-1 infant vaccine in healthy babies
This study tests a new vaccine that protects babies against 6 diseases (diphtheria, tetanus, whooping cough, hepatitis B, polio, and Hib) in just one shot. It’s for healthy infants starting at 6–8 weeks old as their first series of vaccinations.
Dasmariñas, CaviteAges 1 month–2 months - NCT07107932Recruiting
Registry for Tetanus Prevention After Injury
This registry collects information on people who receive the study drug Siltartoxatug to prevent tetanus after an injury. It helps researchers learn more about how the drug works in real-world use.
Shantou, GuangdongAges Any age - NCT06333275Recruiting
Boosting immunity after CAR-T therapy
This trial checks if giving vaccines after CAR-T cell therapy can help your immune system fight off preventable diseases. It is for adults with certain blood cancers who are about to get CAR-T treatment.
BernAges 18 years+ - NCT06997627RecruitingPhase 1/Phase 2
Safety and immune response study of GC3111B vaccine in healthy adults
This trial tests a new vaccine called GC3111B to see if it is safe and helps the body build protection against diphtheria, tetanus, and pertussis (whooping cough). It is for healthy adults who have not had a similar vaccine in the last 2 years.
SeoulAges 19–64 - NCT06639074RecruitingPhase 2
Folate receptor dendritic cell vaccine for ovarian cancer
This trial tests a personalized vaccine made from your own immune cells, designed to target a protein called folate receptor alpha found on many ovarian cancer cells. It is for people who have finished initial chemotherapy and have no signs of cancer remaining, to try to prevent it from coming back.
Scottsdale, ArizonaAges 18 years+ - NCT04843111Recruiting
Registry study for pregnancy exposure to MenQuadfi vaccine
This is an observational registry that collects information about pregnant people and their babies when MenQuadfi® (a meningitis vaccine) was given during pregnancy or shortly before pregnancy. It helps researchers understand what happens to women and offspring after this vaccine exposure.
Swiftwater, PennsylvaniaAges Any age - NCT05096481RecruitingPhase 2
Vaccine trial for children with certain brain tumors
This Phase 2 study tests a vaccine made to target CMV (a virus) in order to treat children with medulloblastoma or newly diagnosed high-grade glioma/DIPG. If you’re eligible, you’d receive the study vaccine and the team would closely watch how well it’s tolerated and how your cancer responds.
Aurora, ColoradoAges 3–39 - NCT05415267RecruitingPhase 3
Boosting COVID protection during long-term immune suppression
This study looks at how well a COVID-19 booster works in adults who need long-term medicines that lower immune response. It aims to see whether immunosuppressed people benefit from booster vaccination safely.
Blacktown, New South WalesAges 18 years+ - NCT06135636RecruitingPhase 4
Helping partners get the Tdap vaccine during pregnancy
This trial tests different ways to help partners of pregnant people get the Tdap vaccine (a shot that protects against tetanus, diphtheria, and whooping cough). The goal is to find the best way to increase vaccination rates among partners, which can help protect the newborn from whooping cough.
Providence, Rhode IslandAges 19–50 - NCT05077137RecruitingPhase 1
Testing an immune memory boost with checkpoint therapy
This early study tests whether “immune recall” (training the immune system using specific vaccine-like steps) can improve how well checkpoint drugs work for advanced melanoma. It is designed mainly to see if the approach is feasible and safe, and it may help some people respond better to PD-1 (with or without CTLA-4) treatment.
Durham, North CarolinaAges 18 years+ - NCT06605755Recruiting
Testing a pentavalent vaccine in 2-month-old babies
This trial tests a combined vaccine that protects against five diseases (diphtheria, tetanus, whooping cough, polio, and Hib) in 2-month-old babies who have already received 4 doses. It aims to check the vaccine's safety and how well it builds immunity.
Nanjing, JiangsuAges 1.6 years–1.8 years - NCT06635798RecruitingPhase 3
Testing a medicine to prevent tetanus after dirty wounds
This trial tests a new medicine called GR2001 to help prevent tetanus after a dirty wound. It is for people who have not had many tetanus shots before and need extra protection.
Hefei, AnhuiAges 18 years+ - NCT06815250Recruiting
Boosting maternal vaccine knowledge and uptake: The InTroDuce-Programme
This trial tests a programme to help pregnant women learn about and get flu and Tdap vaccines. It aims to increase vaccination rates and improve health for mothers and babies.
Bandar Baru Bangi, SelangorAges 18 years+ - NCT07097012RecruitingPhase 4
Whooping cough and RSV vaccines: together or separate in pregnancy
This study tests whether giving two vaccines—one for whooping cough (Tdap) and one for RSV—at the same time is safe and effective compared to giving them separately during pregnancy. It may help protect your baby from both diseases early in life.
Vancouver, British ColumbiaAges 18–49 - NCT07358910Recruiting
Tracking infectious diseases in communities
This study looks at how infections spread in villages in Cambodia. If you live in a participating village, you might help us understand and prevent disease outbreaks.
Phnom Penh, Phnom PenhAges 2–75
Hear when a new Tetanus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for tetanus?
- Yes. Clin2 currently lists 25 recruiting tetanus studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a tetanus trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a tetanus trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.